Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06930846 · ClinicalTrials.gov registry record · NA

HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)

A NA study of Brain Tumor and Brain Cancer, sponsored by Dartmouth-Hitchcock Medical Center.

Recruiting
Registry status
NA
Development phase
125
Enrollment target
1
Study location

NCT06930846 is a NA study of Brain Tumor and Brain Cancer that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 125 participants, below the 280-participant average among 69 other Brain Tumor trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06930846, a NA study of Brain Tumor and Brain Cancer, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.

RECRUITING
Registry status
NA
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the ability of the home-based intervention, HOBSCOTCH-CA, to improve the quality of life and cognitive function in Service Members, Veterans and civilians who are survivors of brain cancer or a brain tumor (CA participants). This study will also assess the ability of the HOBSCOTCH-CA program to improve quality of life in caregivers of patients with brain cancer/tumor and to reduce caregiver burden. Enrolling with a Caregiver is optional for CA participants. Investigators will compare two groups of CA participants and their Caregiver (enrolling with a Caregiver is optional): one who receives HOBSCOCTCH-CA immediately (Group 1) and another group that will receive HOBSCOTCH-CA (Group 2) after a 3-month waiting period. Participants will be in the study for about 6 months total. HOBSCOTCH-CA involves 45 to 60 minute one on one virtual sessions with a certified Cognitive Coach including a "pre" program session and 8 weekly sessions thereafter. Participants will learn about problem solving therapy and mindfulness or relaxation training. CA participants are asked to do short homework assignments and keep a brief daily diary on a smart phone app. All participants complete study questionnaires or surveys at enrollment, 3 months later and at 6 months (at the end of the study).

Interventions

  • BEHAVIORAL HOBSCOTCH-CA

Study Locations (1)

New Hampshire

  • Dartmouth-Health Lebanon - Lebanon

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2025-11-03
Est. Completion 2028-12
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT06930846

The ClinicalTrials.gov registry entry for NCT06930846 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 280-participant average among 69 other Brain Tumor trials with a reported enrollment target (55% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which HOBSCOTCH-CA is the first listed.

NCT06930846 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT06930846 about?

NCT06930846 is a clinical study titled "HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)". The purpose of this study is to assess the ability of the home-based intervention, HOBSCOTCH-CA, to improve the quality of life and cognitive function in Service Members, Veterans and civilians who are survivors of brain cancer or a brain tumor (CA participants). This study will also assess the abil...

What is the current status of trial NCT06930846?

This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2025-11-03. Estimated completion is 2028-12.

What conditions does trial NCT06930846 study?

This clinical trial studies the following conditions: Brain Tumor, Brain Cancer, Cognitive Dysfunction, Low Grade Glioma, Meningioma.

What interventions are being tested in trial NCT06930846?

The interventions under investigation include: HOBSCOTCH-CA (BEHAVIORAL).

Who is sponsoring clinical trial NCT06930846?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06930846 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.